252 related articles for article (PubMed ID: 20544224)
1. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea.
Elad S; Zadik Y; Hewson I; Hovan A; Correa ME; Logan R; Elting LS; Spijkervet FK; Brennan MT;
Support Care Cancer; 2010 Aug; 18(8):993-1006. PubMed ID: 20544224
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.
Elad S; Ranna V; Ariyawardana A; Correa ME; Tilly V; Nair RG; Rouleau T; Logan RM; Pinto A; Charette V; Saunders DP; Jensen SB;
Support Care Cancer; 2017 Feb; 25(2):687-700. PubMed ID: 27853930
[TBL] [Abstract][Full Text] [Related]
3. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
[TBL] [Abstract][Full Text] [Related]
4. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
Warkentin DI; Epstein JB; Campbell LM; Yip JG; Cox VC; Ransier A; Barnett MJ; Marra F
Ann Pharmacother; 2002 Oct; 36(10):1525-31. PubMed ID: 12243600
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis.
Aribi Al-Zoobaee FW; Yee Shen L; Veettil SK; Gopinath D; Maharajan MK; Menon RK
Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33265920
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
[TBL] [Abstract][Full Text] [Related]
8. Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
Wu JJ; Brentjens MH; Torres G; Yeung-Yue K; Lee P; Tyring SK
J Cutan Med Surg; 2003; 7(5):372-81. PubMed ID: 14505192
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus infection.
Whitley RJ
Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
[TBL] [Abstract][Full Text] [Related]
10. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review.
Sheffield JS; Hollier LM; Hill JB; Stuart GS; Wendel GD
Obstet Gynecol; 2003 Dec; 102(6):1396-403. PubMed ID: 14662233
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
[TBL] [Abstract][Full Text] [Related]
14. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.
Liesveld JL; Abboud CN; Ifthikharuddin JJ; Lancet JE; Wedow LA; Oliva J; Stamm CG; Nichols D
Biol Blood Marrow Transplant; 2002; 8(12):662-5. PubMed ID: 12523578
[TBL] [Abstract][Full Text] [Related]
15. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
16. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
18. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.
Kimberlin D; Powell D; Gruber W; Diaz P; Arvin A; Kumar M; Jacobs R; Van Dyke R; Burchett S; Soong SJ; Lakeman A; Whitley R
Pediatr Infect Dis J; 1996 Mar; 15(3):247-54. PubMed ID: 8852914
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Lee DH; Zuckerman RA;
Clin Transplant; 2019 Sep; 33(9):e13526. PubMed ID: 30859647
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study.
Ramphal R; Grant RM; Dzolganovski B; Constantin J; Tellier R; Allen U; Weitzman S; Matlow A; Petric M; Sung L
Pediatr Infect Dis J; 2007 Aug; 26(8):700-4. PubMed ID: 17848881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
